Based on these findings, it is possible to hypothesize that although the upregulation of the P13K-AKT pathway in hASCs may lead to insulin resistance, the identified targets have the potential to restore normal glucose metabolism through alternative pathways. The gene discussed is AKT1; the disease is Insulin resistance.